diff --git "a/benchmark.csv" "b/benchmark.csv"
new file mode 100644--- /dev/null
+++ "b/benchmark.csv"
@@ -0,0 +1,2990 @@
+prompt,hit
+Does knockout of Gart in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Bap1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Tkt in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ppat in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mthfd1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rpl27a in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Eif4a1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rpl8 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Pfas in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rps3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rps3a1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rpe in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mocs3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Umps in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Elp3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Sepsecs in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Sin3a in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rpl13 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Chd4 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Eif3d in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Eif3g in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Exosc10 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rps27 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Eif3i in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Brd2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rps5 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Dph3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rpl4 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Elp5 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Eif1ad in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of N6amt1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Pelo in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Nmnat1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Dis3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ypel5 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rps13 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Eif3c in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rps6 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rpl36a in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rps16 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Fau in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Eefsec in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Pwp1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Wdr74 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rps7 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Polr2b in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Slc25a26 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Elp2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rps29 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rplp2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Fam204a in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Pdap1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rpl15 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Dhfr in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Xpo1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rpl26 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Polg2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rps4x in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Polr1b in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ctu2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rpl18 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Pcna in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Emg1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Sap130 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ddx21 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Sbds in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rps15a in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Fxn in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ppcs in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Pak1ip1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mrpl41 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rpl6 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rps11 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Anapc11 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rpl35 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Prdm10 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mtg2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Eif2s1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Keap1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ctdnep1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rrp9 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Tmx2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Tyms in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Coa5 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rps9 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rpl19 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Suds3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Nmnat2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ctu1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Polr1e in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rpl34 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rpl18a in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Atad3a in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Grpel1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Tut1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Eif3h in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rps24 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Cycs in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Elp6 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Cdc23 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mta2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Tpi1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Atxn7l3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Fam98b in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Heatr3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Pds5b in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Gnl3l in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Haus1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Taf11 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Strap in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Heatr1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Birc5 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Wdr5 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Nip7 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Psmc5 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ppcdc in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Cbll1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Vars2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mrpl38 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Hsd17b10 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Pyroxd1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Timm10 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mrps15 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Toe1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Nudcd2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Nufip1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Dhx33 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Noc4l in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ndufa1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rps27rt in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Tiprl in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Nat10 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Flii in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Eral1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Tsr1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ing1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rpl37 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Nop10 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mrps34 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Cpsf4 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Wdr25 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rps10 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Dars2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mrpl44 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Pabpn1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Eif5 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rfk in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Nup98 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Srd5a3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Eif4b in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Lsm11 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rpl17 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Sephs2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Adat3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Aasdhppt in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Sars2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Dhodh in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ubtf in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Nelfcd in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Atl2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Pin1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Cmtr2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rps15 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Zcchc9 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Eef1g in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mrpl20 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Wdr77 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rpl3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Chordc1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mettl23 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Cstf3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Alad in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Eif3b in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Vps11 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mms19 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ctr9 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Snrpg in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Dnajc2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Tpt1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Cdk2ap1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ruvbl1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Zbtb8os in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mup16 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Dclre1b in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Erh in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rps8 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ddx47 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Myc in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Kansl3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ogdh in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ttf1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Nup133 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Tbp in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rpl41 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Dmap1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Adnp in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Nob1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ctc1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Nup54 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rplp0 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Uros in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mrpl55 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Cdc45 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Setdb1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Memo1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Cpox in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rpl28 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Atic in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Pdcd11 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Uqcr10 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rcc1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Exosc1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Smc5 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Grwd1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Parn in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Bms1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Trim28 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rpn1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Dbr1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Opa1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rbbp4 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Aldoa in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Dnaaf5 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Dkc1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Gatad2a in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Paf1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Prmt5 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ddx19a in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Tuba1a in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Lars2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Pgd in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Matr3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Eif3m in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Hmbs in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Hsp90ab1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mars2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Tmem70 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rpl23a in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Cox17 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mbtps1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Top1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Tefm in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Txnrd1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Esf1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Krr1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Eef2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mios in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Urm1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Hmgcs1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Cebpz in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Lamtor1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Psmc6 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Vrk1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Nelfb in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rae1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Polrmt in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Wdr33 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Nop16 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Vps33a in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mak16 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rpl31 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ybey in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Pop5 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Supt5 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Cct3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ppa2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Timm13 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Med22 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Pnkp in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rpl14 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Top2a in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rac1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Alg8 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mphosph6 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Imp3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Adat2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Tspyl1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Hjurp in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ptpn11 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Vhl in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Eif3j1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Dph6 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rpp38 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ube4b in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Polr1a in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rnaseh2a in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rps26 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Pde12 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Cenpo in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mrpl23 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ppp2r3c in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rpsa in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Dph1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Tcea1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Armc7 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Supt4a in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Coa6 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Gtf2b in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Dnajc9 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Wdr48 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Snupn in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Nop9 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Dolpp1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Frat2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ddx1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Lsg1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Snrpd3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Bccip in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Pgk1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Dhps in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Pabpc1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rps18 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Zc3h18 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mfap1b in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Cpsf2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Actr2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mlst8 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Psmb2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Utp15 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Clasrp in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Eif1ax in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ndufb3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mrpl49 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rtn4ip1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Itpk1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Cpsf1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Dhx37 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Slc4a7 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ect2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Gins1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mkln1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Eif5a in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Taf13 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ipmk in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rps17 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Dnajc8 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Smc4 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Pggt1b in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Cars2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ndrg3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ak2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Nolc1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Uqcrfs1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ppih in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Fam32a in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ss18 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ppp6c in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Prpf19 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Sec13 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mpi in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Urb1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Elp4 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Thoc7 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Nr2c2ap in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rpl7a in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Lsm10 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Klhdc3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Puf60 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ostc in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Lamtor4 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mipep in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Kansl2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Bex6 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rrp1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Acat3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rcc2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ybx1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rpl39 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rbm19 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ngdn in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Cct5 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Dnmt1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Psma7 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Morf4l2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mtx2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Sco2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Med24 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Pisd in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Nmd3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ndufaf7 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ndufs1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Dohh in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Anapc4 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Wdr24 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ndufaf1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Eif2b4 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Urod in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mrpl17 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Pars2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ilf3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mrps16 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Coq6 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Usp22 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Arid4b in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Trub2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Cyc1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Denr in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Wdr18 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Arhgap11a in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ncapd2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ctcf in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Foxk2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Taf1c in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Scd2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Tecr in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Pfn1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Alg11 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Cenpu in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ermp1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ncbp1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Baz1b in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ppil2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rnaseh1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ankrd52 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Polr3h in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Atp1a1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ddx49 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ccnt1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Hnrnpab in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rps27a in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Syncrip in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Tufm in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Gnl2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Trrap in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rps19bp1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ddx18 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Cuta in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Hsd17b12 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Txn2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Dynlrb1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ciapin1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Sap18 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Nrbp2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Nsd1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Map2k7 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Dennd6a in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Pet117 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Sco1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mrps28 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Trit1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Dlst in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Sod2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Tra2b in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Dnajc11 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rpl7 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Gm4836 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Leo1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Zfp65 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rps14 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Fam118a in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ap2s1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Phb2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Gatb in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Uqcc2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ndufs2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Bend3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ranbp2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Thap1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ncbp2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Gins3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Tmem208 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Sox10 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mrps11 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Zbtb17 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Bop1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Kras in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Nxf1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rnaseh2c in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Hspa5 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Prmt1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Eif4e in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Dnm1l in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Dusp12 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rev1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Vps16 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Srsf11 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Fbl in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Stoml2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mrpl16 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Atp6v0c in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mrpl33 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mad2l1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Acat2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Gm9758 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rpl30 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rbm41 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Cstf2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Vmn2r36 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Fh1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Smc6 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ndufb8 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Shf in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Kat8 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Polr3f in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ppan in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Alyref in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Nup62 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mrpl52 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Wdr82 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rps12 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Abca2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Nek8 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of R3hdm1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Fars2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ppp1r8 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Alas1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Cct8 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mapkap1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Phf21a in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Timm9 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Smc1a in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Sf3b6 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Nutf2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Eif4ebp3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Glrx5 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Nhp2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rsl24d1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Psmg4 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Atg9a in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Seh1l in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Caap1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Supt20 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Plekhh3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Pdss2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mrpl14 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ddx54 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Eif3e in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Wdr75 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Nol6 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Nol12 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Slc38a2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Pop7 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mcrs1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rai1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Hnrnpl in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Get4 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Bptf in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Nup43 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Zdhhc16 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Fgfr1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Lrrc69 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Imp4 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Wdr73 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Xrn2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Surf6 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Itgb1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ccdc86 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Wdr27 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Myt1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ppp4r2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Vac14 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Nckap1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of BC005624 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Brix1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Olig2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Syt3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Pdss1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Atp6v0b in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Coq5 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Supt6 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Uba5 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Syvn1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Magoh in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Nars2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mrpl3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Usp36 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mrpl15 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Btaf1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Gpr160 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mrpl54 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ei24 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Chmp6 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ppp1r10 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Fdxr in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Lin54 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Trmt6 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Gm13057 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Itga6 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Cdk7 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ints6 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Slc29a4 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Cox15 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Polr3c in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rtcb in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rexo2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ddx10 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Wars2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mvk in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Pga5 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Clp1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Adamdec1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Gm10408 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mrps17 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Lrr1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Tmem126b in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Tbca in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Gm2897 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Chmp2a in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ckap5 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Sdhaf2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Eif3f in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of 2700062C07Rik in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Slc25a19 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mrpl53 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Eif3a in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mfn2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Abce1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Cdkn2a in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Cad in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Psmd13 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Cep55 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Vps18 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ttc14 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ptcd1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Snx7 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Chmp3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Nudc in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Igf1r in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Exosc3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Cenpp in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rps20 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Kti12 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Srsf5 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Gigyf1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rrp36 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Tomm70a in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Pik3c2a in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Sdhc in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Fus in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Acly in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rapgef1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Pnpt1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Bri3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Nsun4 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Bcl7a in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Gm15127 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Med13 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mbip in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Sptlc1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Tmprss4 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Lig3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Scd3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Atp1b3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Dhx16 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Plrg1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ifna12 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Edc3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Cmpk1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Cdh2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mrpl45 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Gstcd in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Actr10 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Prpf18 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Pkm in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Tbcc in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Usp8 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ssbp1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Chchd3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Tectb in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ccl19 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Sp2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Dcaf13 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Gm17019 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Serpine1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Yae1d1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Paqr5 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Tmem186 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Dna2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Jun in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Smu1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Cherp in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Gtpbp4 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Abcf2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Sptlc2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Irf9 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Sdhd in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ten1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Tprkb in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Sirt6 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Med4 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ipo11 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mrpl19 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rabggta in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rpl7l1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Coq4 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Camk1d in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ints5 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Lsm12 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Dctn5 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rpa2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Pbrm1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Dhx38 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Riok1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rprd1b in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Cdk4 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Vmn2r42 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Kdm2a in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Krtap5-4 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mybl2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Lonp1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mrap in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Elac2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ncl in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ep300 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mrps2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Kntc1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Exosc5 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Gm3488 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Snrpf in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ndufb9 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rps23 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Cryzl1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rabggtb in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Nhlrc2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Eif4h in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Nme6 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rhod in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Nup188 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Fads2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rpn2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Usp16 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Zbtb14 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Lrrc10 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Vmn1r11 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Sec22b in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Pgam1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Pa2g4 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Sel1l in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mrpl12 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of C4b in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Nfx1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Pacsin1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Pofut2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Trim34b in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Timmdc1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of H2-T3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Yeats4 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Zfp534 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Spc24 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Axin1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Donson in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rps28 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ssrp1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rhox3e in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Gnl3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Tmem201 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Pwp2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ddx52 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Eif2s2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mbd3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ubl5 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rps25 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Yrdc in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Asns in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Pdcd10 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Pfdn5 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mrpl4 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Sds in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mrps33 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Frs2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Krtap10-4 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Vmn1r79 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Isca1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Zfp652 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Atxn2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Psma1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Slc25a32 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Dhrs7b in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rpl32 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Trmu in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Zbtb26 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Kctd4 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Gramd4 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rrp15 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Foxn2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Fanca in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mrps18b in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mis12 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mycbp in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rbm27 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ufm1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Tex19.1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mical2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Kdm1a in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mecr in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Psma5 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Farsb in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Slbp in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Asb3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Aco2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mup9 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Nop2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mdn1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Apol11a in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Tgtp2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Ufc1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rad21 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mcat in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Sowahc in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Rictor in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Uqcrc1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Mrpl39 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Manf in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Map3k15 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Gfm2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Gtf2f1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Zfp628 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Psmd4 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,0
+Does knockout of Pigk in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Rmnd5a in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Smad4 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Cap2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Wbp4 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Huwe1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Smg7 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Aadac in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Zbtb11 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Ttc39d in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Birc6 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Trappc4 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Ogt in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Gigyf2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Rrm2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Lztr1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Zfp937 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Hira in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Ccnf in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Meaf6 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Pold1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Gps2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Zc3h7b in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Snip1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Nfib in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Usp19 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Gbp10 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Ube2a in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Lsm1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Lpgat1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Cbl in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Cwc27 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Rnf40 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Mitd1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Mier3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Zfx in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Chek1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Otud5 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Kpna2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Ranbp9 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Hdac8 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Brap in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Tfpt in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Nosip in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Ubr5 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Cadm1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Maea in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Kpnb1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Nprl2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Ezh2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Zfp36l2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Rest in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Lig1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Sf3b5 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Rnf146 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Cyp51 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Tsc2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Vcpip1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Abcc1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Ube2h in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Gid8 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Nprl3 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Upf1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Usp18 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Morf4l1 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Trip12 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Upf2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Sumo2 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Wdr26 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Cdyl in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Spop in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Sox6 in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Nt5c3b in NG2-3112 mouse glioblastoma cells causally result in increased sensitivity to gliocidin and subsequently glioblastoma cell death?,1
+Does knockout of Stk11 in 3LL Lewis lung carcinoma cells causally result in increased resistance to PD1 blockade and lung carcinoma cell survival?,1
+Does knockout of H2-K1 in 3LL Lewis lung carcinoma cells causally result in increased resistance to PD1 blockade and lung carcinoma cell survival?,1
+Does knockout of Keap1 in 3LL Lewis lung carcinoma cells causally result in increased resistance to PD1 blockade and lung carcinoma cell survival?,1
+Does knockout of Pcna in 3LL Lewis lung carcinoma cells causally result in increased resistance to PD1 blockade and lung carcinoma cell survival?,1
+Does knockout of Top1 in 3LL Lewis lung carcinoma cells causally result in increased resistance to PD1 blockade and lung carcinoma cell survival?,1
+Does knockout of Setdb1 in 3LL Lewis lung carcinoma cells causally result in increased resistance to PD1 blockade and lung carcinoma cell survival?,1
+Does knockout of Map3k1 in 3LL Lewis lung carcinoma cells causally result in increased resistance to PD1 blockade and lung carcinoma cell survival?,1
+Does knockout of Egfr in 3LL Lewis lung carcinoma cells causally result in increased resistance to PD1 blockade and lung carcinoma cell survival?,1
+Does knockout of Tsc2 in 3LL Lewis lung carcinoma cells causally result in increased resistance to PD1 blockade and lung carcinoma cell survival?,1
+Does knockout of Setd2 in 3LL Lewis lung carcinoma cells causally result in increased resistance to PD1 blockade and lung carcinoma cell survival?,1
+Does knockout of Tap1 in 3LL Lewis lung carcinoma cells causally result in increased resistance to PD1 blockade and lung carcinoma cell survival?,1
+Does knockout of Casp8 in 3LL Lewis lung carcinoma cells causally result in increased resistance to PD1 blockade and lung carcinoma cell survival?,1
+Does knockout of Rps6 in 3LL Lewis lung carcinoma cells causally result in increased resistance to PD1 blockade and lung carcinoma cell survival?,1
+Does knockout of Men1 in 3LL Lewis lung carcinoma cells causally result in increased resistance to PD1 blockade and lung carcinoma cell survival?,1
+Does knockout of Cd47 in 3LL Lewis lung carcinoma cells causally result in increased resistance to PD1 blockade and lung carcinoma cell survival?,1
+Does knockout of Asxl1 in 3LL Lewis lung carcinoma cells causally result in increased resistance to PD1 blockade and lung carcinoma cell survival?,1
+Does knockout of Sufu in 3LL Lewis lung carcinoma cells causally result in increased resistance to PD1 blockade and lung carcinoma cell survival?,1
+Does knockout of B2m in 3LL Lewis lung carcinoma cells causally result in increased resistance to PD1 blockade and lung carcinoma cell survival?,1
+Does knockout of Stat1 in 3LL Lewis lung carcinoma cells causally result in increased resistance to PD1 blockade and lung carcinoma cell survival?,1
+Does knockout of Tbk1 in 3LL Lewis lung carcinoma cells causally result in increased resistance to PD1 blockade and lung carcinoma cell survival?,1
+Does knockout of Jak1 in 3LL Lewis lung carcinoma cells causally result in increased resistance to PD1 blockade and lung carcinoma cell survival?,1
+Does knockout of Afdn in 3LL Lewis lung carcinoma cells causally result in increased resistance to PD1 blockade and lung carcinoma cell survival?,1
+Does knockout of Fbxw7 in 3LL Lewis lung carcinoma cells causally result in increased resistance to PD1 blockade and lung carcinoma cell survival?,1
+Does knockout of Cbfb in 3LL Lewis lung carcinoma cells causally result in increased resistance to PD1 blockade and lung carcinoma cell survival?,0
+Does knockout of Ptpn2 in 3LL Lewis lung carcinoma cells causally result in increased resistance to PD1 blockade and lung carcinoma cell survival?,0
+Does knockout of Rpl18 in 3LL Lewis lung carcinoma cells causally result in increased resistance to PD1 blockade and lung carcinoma cell survival?,0
+Does knockout of Gart in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Bap1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Tkt in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ppat in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mthfd1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rpl27a in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Eif4a1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rpl8 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Pfas in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rps3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rps3a1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rpe in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mocs3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Umps in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Elp3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Sepsecs in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Sin3a in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rpl13 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Chd4 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Eif3d in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Eif3g in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Exosc10 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rps27 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Eif3i in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Brd2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rps5 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Dph3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rpl4 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Elp5 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Eif1ad in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of N6amt1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Pelo in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Nmnat1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Dis3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ypel5 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rps13 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Eif3c in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rps6 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rpl36a in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rps16 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Fau in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Eefsec in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Pwp1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Wdr74 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rps7 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Polr2b in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Slc25a26 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Elp2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rps29 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rplp2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Fam204a in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Pdap1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rpl15 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Dhfr in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Xpo1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rpl26 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Polg2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rps4x in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Polr1b in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ctu2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rpl18 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Pcna in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Emg1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Sap130 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ddx21 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Sbds in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rps15a in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Fxn in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ppcs in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Pak1ip1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mrpl41 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rpl6 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rps11 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Anapc11 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rpl35 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Prdm10 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mtg2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Eif2s1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Keap1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ctdnep1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rrp9 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Tmx2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Tyms in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Coa5 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rps9 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rpl19 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Suds3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Nmnat2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ctu1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Polr1e in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rpl34 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rpl18a in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Atad3a in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Grpel1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Tut1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Eif3h in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rps24 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Cycs in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Elp6 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Cdc23 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mta2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Tpi1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Atxn7l3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Fam98b in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Heatr3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Pds5b in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Gnl3l in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Haus1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Taf11 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Strap in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Heatr1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Birc5 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Wdr5 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Nip7 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Psmc5 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ppcdc in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Cbll1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Vars2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mrpl38 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Hsd17b10 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Pyroxd1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Timm10 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mrps15 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Toe1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Nudcd2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Nufip1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Dhx33 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Noc4l in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ndufa1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rps27rt in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Tiprl in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Nat10 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Flii in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Eral1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Tsr1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ing1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rpl37 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Nop10 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mrps34 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Cpsf4 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Wdr25 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rps10 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Dars2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mrpl44 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Pabpn1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Eif5 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rfk in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Nup98 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Srd5a3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Eif4b in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Lsm11 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rpl17 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Sephs2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Adat3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Aasdhppt in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Sars2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Dhodh in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ubtf in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Nelfcd in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Atl2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Pin1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Cmtr2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rps15 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Zcchc9 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Eef1g in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mrpl20 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Wdr77 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rpl3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Chordc1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mettl23 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Cstf3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Alad in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Eif3b in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Vps11 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mms19 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ctr9 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Snrpg in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Dnajc2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Tpt1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Cdk2ap1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ruvbl1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Zbtb8os in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mup16 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Dclre1b in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Erh in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rps8 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ddx47 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Myc in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Kansl3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ogdh in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ttf1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Nup133 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Tbp in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rpl41 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Dmap1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Adnp in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Nob1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ctc1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Nup54 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rplp0 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Uros in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mrpl55 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Cdc45 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Setdb1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Memo1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Cpox in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rpl28 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Atic in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Pdcd11 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Uqcr10 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rcc1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Exosc1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Smc5 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Grwd1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Parn in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Bms1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Trim28 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rpn1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Dbr1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Opa1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rbbp4 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Aldoa in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Dnaaf5 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Dkc1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Gatad2a in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Paf1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Prmt5 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ddx19a in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Tuba1a in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Lars2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Pgd in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Matr3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Eif3m in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Hmbs in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Hsp90ab1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mars2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Tmem70 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rpl23a in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Cox17 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mbtps1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Top1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Tefm in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Txnrd1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Esf1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Krr1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Eef2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mios in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Urm1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Hmgcs1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Cebpz in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Lamtor1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Psmc6 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Vrk1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Nelfb in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rae1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Polrmt in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Wdr33 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Nop16 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Vps33a in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mak16 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rpl31 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ybey in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Pop5 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Supt5 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Cct3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ppa2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Timm13 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Med22 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Pnkp in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rpl14 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Top2a in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rac1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Alg8 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mphosph6 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Imp3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Adat2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Tspyl1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Hjurp in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ptpn11 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Vhl in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Eif3j1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Dph6 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rpp38 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ube4b in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Polr1a in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rnaseh2a in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rps26 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Pde12 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Cenpo in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mrpl23 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ppp2r3c in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rpsa in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Dph1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Tcea1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Armc7 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Supt4a in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Coa6 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Gtf2b in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Dnajc9 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Wdr48 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Snupn in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Nop9 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Dolpp1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Frat2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ddx1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Lsg1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Snrpd3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Bccip in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Pgk1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Dhps in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Pabpc1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rps18 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Zc3h18 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mfap1b in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Cpsf2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Actr2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mlst8 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Psmb2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Utp15 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Clasrp in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Eif1ax in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ndufb3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mrpl49 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rtn4ip1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Itpk1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Cpsf1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Dhx37 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Slc4a7 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ect2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Gins1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mkln1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Eif5a in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Taf13 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ipmk in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rps17 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Dnajc8 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Smc4 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Pggt1b in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Cars2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ndrg3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ak2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Nolc1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Uqcrfs1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ppih in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Fam32a in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ss18 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ppp6c in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Prpf19 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Sec13 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mpi in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Urb1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Elp4 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Thoc7 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Nr2c2ap in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rpl7a in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Lsm10 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Klhdc3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Puf60 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ostc in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Lamtor4 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mipep in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Kansl2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Bex6 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rrp1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Acat3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rcc2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ybx1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rpl39 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rbm19 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ngdn in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Cct5 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Dnmt1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Psma7 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Morf4l2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mtx2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Sco2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Med24 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Pisd in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Nmd3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ndufaf7 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ndufs1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Dohh in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Anapc4 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Wdr24 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ndufaf1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Eif2b4 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Urod in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mrpl17 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Pars2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ilf3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mrps16 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Coq6 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Usp22 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Arid4b in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Trub2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Cyc1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Denr in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Wdr18 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Arhgap11a in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ncapd2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ctcf in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Foxk2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Taf1c in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Scd2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Tecr in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Pfn1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Alg11 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Cenpu in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ermp1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ncbp1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Baz1b in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ppil2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rnaseh1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ankrd52 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Polr3h in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Atp1a1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ddx49 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ccnt1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Hnrnpab in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rps27a in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Syncrip in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Tufm in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Gnl2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Trrap in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rps19bp1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ddx18 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Cuta in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Hsd17b12 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Txn2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Dynlrb1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ciapin1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Sap18 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Nrbp2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Nsd1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Map2k7 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Dennd6a in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Pet117 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Sco1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mrps28 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Trit1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Dlst in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Sod2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Tra2b in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Dnajc11 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rpl7 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Gm4836 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Leo1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Zfp65 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rps14 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Fam118a in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ap2s1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Phb2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Gatb in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Uqcc2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ndufs2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Bend3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ranbp2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Thap1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ncbp2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Gins3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Tmem208 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Sox10 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mrps11 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Zbtb17 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Bop1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Kras in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Nxf1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rnaseh2c in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Hspa5 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Prmt1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Eif4e in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Dnm1l in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Dusp12 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rev1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Vps16 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Srsf11 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Fbl in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Stoml2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mrpl16 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Atp6v0c in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mrpl33 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mad2l1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Acat2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Gm9758 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rpl30 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rbm41 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Cstf2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Vmn2r36 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Fh1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Smc6 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ndufb8 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Shf in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Kat8 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Polr3f in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ppan in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Alyref in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Nup62 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mrpl52 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Wdr82 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rps12 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Abca2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Nek8 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of R3hdm1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Fars2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ppp1r8 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Alas1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Cct8 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mapkap1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Phf21a in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Timm9 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Smc1a in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Sf3b6 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Nutf2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Eif4ebp3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Glrx5 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Nhp2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rsl24d1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Psmg4 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Atg9a in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Seh1l in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Caap1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Supt20 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Plekhh3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Pdss2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mrpl14 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ddx54 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Eif3e in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Wdr75 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Nol6 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Nol12 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Slc38a2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Pop7 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mcrs1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rai1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Hnrnpl in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Get4 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Bptf in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Nup43 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Zdhhc16 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Fgfr1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Lrrc69 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Imp4 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Wdr73 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Xrn2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Surf6 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Itgb1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ccdc86 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Wdr27 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Myt1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ppp4r2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Vac14 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Nckap1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of BC005624 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Brix1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Olig2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Syt3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Pdss1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Atp6v0b in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Coq5 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Supt6 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Uba5 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Syvn1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Magoh in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Nars2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mrpl3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Usp36 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mrpl15 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Btaf1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Gpr160 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mrpl54 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ei24 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Chmp6 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ppp1r10 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Fdxr in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Lin54 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Trmt6 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Gm13057 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Itga6 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Cdk7 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ints6 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Slc29a4 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Cox15 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Polr3c in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rtcb in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rexo2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ddx10 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Wars2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mvk in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Pga5 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Clp1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Adamdec1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Gm10408 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mrps17 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Lrr1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Tmem126b in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Tbca in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Gm2897 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Chmp2a in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ckap5 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Sdhaf2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Eif3f in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of 2700062C07Rik in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Slc25a19 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mrpl53 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Eif3a in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mfn2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Abce1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Cdkn2a in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Cad in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Psmd13 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Cep55 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Vps18 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ttc14 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ptcd1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Snx7 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Chmp3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Nudc in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Igf1r in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Exosc3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Cenpp in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rps20 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Kti12 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Srsf5 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Gigyf1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rrp36 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Tomm70a in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Pik3c2a in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Sdhc in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Fus in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Acly in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rapgef1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Pnpt1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Bri3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Nsun4 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Bcl7a in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Gm15127 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Med13 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mbip in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Sptlc1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Tmprss4 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Lig3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Scd3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Atp1b3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Dhx16 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Plrg1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ifna12 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Edc3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Cmpk1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Cdh2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mrpl45 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Gstcd in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Actr10 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Prpf18 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Pkm in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Tbcc in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Usp8 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ssbp1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Chchd3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Tectb in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ccl19 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Sp2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Dcaf13 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Gm17019 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Serpine1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Yae1d1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Paqr5 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Tmem186 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Dna2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Jun in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Smu1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Cherp in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Gtpbp4 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Abcf2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Sptlc2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Irf9 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Sdhd in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ten1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Tprkb in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Sirt6 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Med4 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ipo11 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mrpl19 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rabggta in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rpl7l1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Coq4 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Camk1d in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ints5 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Lsm12 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Dctn5 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rpa2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Pbrm1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Dhx38 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Riok1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rprd1b in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Cdk4 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Vmn2r42 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Kdm2a in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Krtap5-4 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mybl2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Lonp1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mrap in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Elac2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ncl in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ep300 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mrps2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Kntc1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Exosc5 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Gm3488 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Snrpf in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ndufb9 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rps23 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Cryzl1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rabggtb in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Nhlrc2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Eif4h in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Nme6 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rhod in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Nup188 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Fads2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rpn2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Usp16 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Zbtb14 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Lrrc10 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Vmn1r11 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Sec22b in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Pgam1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Pa2g4 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Sel1l in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mrpl12 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of C4b in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Nfx1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Pacsin1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Pofut2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Trim34b in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Timmdc1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of H2-T3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Yeats4 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Zfp534 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Spc24 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Axin1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Donson in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rps28 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ssrp1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rhox3e in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Gnl3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Tmem201 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Pwp2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ddx52 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Eif2s2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mbd3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ubl5 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rps25 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Yrdc in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Asns in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Pdcd10 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Pfdn5 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mrpl4 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Sds in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mrps33 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Frs2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Krtap10-4 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Vmn1r79 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Isca1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Zfp652 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Atxn2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Psma1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Slc25a32 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Dhrs7b in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rpl32 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Trmu in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Zbtb26 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Kctd4 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Gramd4 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rrp15 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Foxn2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Fanca in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mrps18b in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mis12 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mycbp in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rbm27 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ufm1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Tex19.1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mical2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Kdm1a in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mecr in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Psma5 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Farsb in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Slbp in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Asb3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Aco2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mup9 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Nop2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mdn1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Apol11a in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Tgtp2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Ufc1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rad21 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mcat in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Sowahc in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Rictor in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Uqcrc1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Mrpl39 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Manf in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Map3k15 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Gfm2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Gtf2f1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Zfp628 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Psmd4 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,1
+Does knockout of Pigk in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Rmnd5a in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Smad4 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Cap2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Wbp4 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Huwe1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Smg7 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Aadac in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Zbtb11 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Ttc39d in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Birc6 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Trappc4 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Ogt in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Gigyf2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Rrm2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Lztr1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Zfp937 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Hira in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Ccnf in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Meaf6 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Pold1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Gps2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Zc3h7b in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Snip1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Nfib in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Usp19 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Gbp10 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Ube2a in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Lsm1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Lpgat1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Cbl in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Cwc27 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Rnf40 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Mitd1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Mier3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Zfx in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Chek1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Otud5 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Kpna2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Ranbp9 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Hdac8 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Brap in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Tfpt in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Nosip in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Ubr5 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Cadm1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Maea in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Kpnb1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Nprl2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Ezh2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Zfp36l2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Rest in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Lig1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Sf3b5 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Rnf146 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Cyp51 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Tsc2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Vcpip1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Abcc1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Ube2h in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Gid8 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Nprl3 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Upf1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Usp18 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Morf4l1 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Trip12 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Upf2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Sumo2 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Wdr26 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Cdyl in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Spop in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Sox6 in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Nt5c3b in NG2-3112 mouse glioblastoma cells causally result in decreased sensitivity to gliocidin and subsequently glioblastoma cell survival?,0
+Does knockout of Stk11 in 3LL Lewis lung carcinoma cells causally result in decreased resistance to PD1 blockade and lung carcinoma cell death?,0
+Does knockout of H2-K1 in 3LL Lewis lung carcinoma cells causally result in decreased resistance to PD1 blockade and lung carcinoma cell death?,0
+Does knockout of Keap1 in 3LL Lewis lung carcinoma cells causally result in decreased resistance to PD1 blockade and lung carcinoma cell death?,0
+Does knockout of Pcna in 3LL Lewis lung carcinoma cells causally result in decreased resistance to PD1 blockade and lung carcinoma cell death?,0
+Does knockout of Top1 in 3LL Lewis lung carcinoma cells causally result in decreased resistance to PD1 blockade and lung carcinoma cell death?,0
+Does knockout of Setdb1 in 3LL Lewis lung carcinoma cells causally result in decreased resistance to PD1 blockade and lung carcinoma cell death?,0
+Does knockout of Map3k1 in 3LL Lewis lung carcinoma cells causally result in decreased resistance to PD1 blockade and lung carcinoma cell death?,0
+Does knockout of Egfr in 3LL Lewis lung carcinoma cells causally result in decreased resistance to PD1 blockade and lung carcinoma cell death?,0
+Does knockout of Tsc2 in 3LL Lewis lung carcinoma cells causally result in decreased resistance to PD1 blockade and lung carcinoma cell death?,0
+Does knockout of Setd2 in 3LL Lewis lung carcinoma cells causally result in decreased resistance to PD1 blockade and lung carcinoma cell death?,0
+Does knockout of Tap1 in 3LL Lewis lung carcinoma cells causally result in decreased resistance to PD1 blockade and lung carcinoma cell death?,0
+Does knockout of Casp8 in 3LL Lewis lung carcinoma cells causally result in decreased resistance to PD1 blockade and lung carcinoma cell death?,0
+Does knockout of Rps6 in 3LL Lewis lung carcinoma cells causally result in decreased resistance to PD1 blockade and lung carcinoma cell death?,0
+Does knockout of Men1 in 3LL Lewis lung carcinoma cells causally result in decreased resistance to PD1 blockade and lung carcinoma cell death?,0
+Does knockout of Cd47 in 3LL Lewis lung carcinoma cells causally result in decreased resistance to PD1 blockade and lung carcinoma cell death?,0
+Does knockout of Asxl1 in 3LL Lewis lung carcinoma cells causally result in decreased resistance to PD1 blockade and lung carcinoma cell death?,0
+Does knockout of Sufu in 3LL Lewis lung carcinoma cells causally result in decreased resistance to PD1 blockade and lung carcinoma cell death?,0
+Does knockout of B2m in 3LL Lewis lung carcinoma cells causally result in decreased resistance to PD1 blockade and lung carcinoma cell death?,0
+Does knockout of Stat1 in 3LL Lewis lung carcinoma cells causally result in decreased resistance to PD1 blockade and lung carcinoma cell death?,0
+Does knockout of Tbk1 in 3LL Lewis lung carcinoma cells causally result in decreased resistance to PD1 blockade and lung carcinoma cell death?,0
+Does knockout of Jak1 in 3LL Lewis lung carcinoma cells causally result in decreased resistance to PD1 blockade and lung carcinoma cell death?,0
+Does knockout of Afdn in 3LL Lewis lung carcinoma cells causally result in decreased resistance to PD1 blockade and lung carcinoma cell death?,0
+Does knockout of Fbxw7 in 3LL Lewis lung carcinoma cells causally result in decreased resistance to PD1 blockade and lung carcinoma cell death?,0
+Does knockout of Cbfb in 3LL Lewis lung carcinoma cells causally result in decreased resistance to PD1 blockade and lung carcinoma cell death?,1
+Does knockout of Ptpn2 in 3LL Lewis lung carcinoma cells causally result in decreased resistance to PD1 blockade and lung carcinoma cell death?,1
+Does knockout of Rpl18 in 3LL Lewis lung carcinoma cells causally result in decreased resistance to PD1 blockade and lung carcinoma cell death?,1
+Does activation of CD28 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of VAV1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of CNR2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of OTUD7B in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of DEF6 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of DEPDC7 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of FOXD2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of HSFX2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of OR2T2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of GPR84 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of LCP2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of TNFRSF9 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of SLC16A1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of MAP2K6 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of PIK3AP1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of TBX21 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of P2RY14 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of ZAP70 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of PLCG2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of IRX4 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of SQSTM1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of OTUD7A in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of FOXQ1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of SERINC3 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of RRAS2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of GPR18 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of TAB3 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of FOXD1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of RER1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of RAC2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of RUNX3 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of VAV3 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of PLEKHG6 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of GEMIN7 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of IL36A in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of LIN9 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of EMP1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of ELAVL3 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of ZDHHC2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of PIK3R6 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of RELA in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of SFN in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of GPR20 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of ABHD6 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of TNFRSF1A in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of CD40 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of FAM129B in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of TF in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of WIPF1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of AKT3 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of PPIL3 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of GPR141 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of MYRF in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of PLAA in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of HCAR2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of TRAF3IP2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of MAP3K8 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of HEPHL1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of AKT1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of SWAP70 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of ZNF296 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of PKIB in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of FAM92A in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of RAB3IL1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of EIF4H in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of RHOG in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of HNRNPA1L2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of KSR2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of CUL1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of ABCA1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of C16orf74 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of PRKCB in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of SIGLEC1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of HLA-DQB1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of SERTM1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of DBP in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of DOLPP1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of SCGB1D1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of EDAR in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of MALT1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of TPGS2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of RASGRP1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of OSTM1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of RPAP1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of OLIG3 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of FAM129A in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of KAT2B in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of TNFRSF8 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of KRT18 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of CBX4 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of TNF in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of NLRC3 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of MAP2K1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of PDPK1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of HERC5 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of ACAP2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of RASD2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of MLC1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of PLAC8 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of PUS3 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of TRIM4 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of LAT in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of CCDC172 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of GPR82 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of HMGCR in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of STAMBPL1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of ZBTB43 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of RFX6 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of FPR2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of WFDC2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of BBS5 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of KLRG1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of STAT5B in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of CAPN1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of TAMM41 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of GSTM1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of LRRC73 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of AIFM2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of CST2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of AP1M2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of TP53I3 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of RORA in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of TCAF2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of TRAM1L1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of CCR8 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of TIMD4 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of RAD51C in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of METTL16 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of AKT2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of C1orf141 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of ELAVL2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of SGTA in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of ZMYM4 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of FABP2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of OR2T6 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of CERS3 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of NRBP2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of FOSL1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of IRF8 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of NT5C1B-RDH14 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,1
+Does activation of TNPO1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of GPHN in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of HOOK1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of PHLDA2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of SPAG1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of IZUMO4 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of GNA15 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of CCNT2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of PLEKHF2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of LCN12 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of FAM110C in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of FER1L5 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of HMGA2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of GSPT1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of TOM1L1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of RAB5B in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of SPAG8 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of TRIM6-TRIM34 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of PRSS35 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of PLEK in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of MMP19 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of EIF3K in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of HLCS in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of QRICH1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of DYNC1I1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of RCCD1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of PCDHGA8 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of ACE in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of PTPN22 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of HES3 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of SAMD4B in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of TRIM71 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of DIRC2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of CD34 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of C16orf96 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of RAB44 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of YTHDF2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of GATA6 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of CIDEB in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of SLC10A4 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of JDP2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of MOB4 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of SMIM7 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of SFMBT1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of ZIM2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of ALPPL2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of PIP4K2B in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of CD200R1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of NXT2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of OR6K3 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of EFNA4 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of ZDHHC7 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of MRPS6 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of OR11H6 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of AFG3L2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of SMIM5 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of RBM27 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of ZNF462 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of RAB19 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of CBLB in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of F7 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of ELOVL4 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of AEBP1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of ARHGAP30 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of C11orf16 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of CA9 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of TMC7 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of TET3 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of OR10A5 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of NTRK1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of GPR132 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of RPUSD3 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of MYC in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of RTN4 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of GFRA4 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of TFCP2L1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of ZNF445 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of RPL39 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of C2orf78 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of DENND1B in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of ZC3HAV1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of BCAM in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of AHR in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of RNF5 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of STK10 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of PIP5K1B in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of PITPNA in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of PPARG in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of TNNT2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of NR2C1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of GABRQ in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of IL18BP in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of CST5 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of HOXD1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of PTBP2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of HIC1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of ADORA2A in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of GPR35 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of SPSB4 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of KIAA1024 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of LHX9 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of PNMA2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of KLHDC8B in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of GPR4 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of USP9X in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of ARHGAP25 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of PEA15 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of TNFRSF14 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of CDK16 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of ELF3 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of IPCEF1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of ATP2A2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of FAM181B in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of BTLA in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of USP38 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of PSTPIP1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of HERC1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of SOX13 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of ARF6 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of CBX8 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of CPXM1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of SOX15 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of HNF1B in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of CAMK4 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of SEPT1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of RREB1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of THSD7A in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of NUDT11 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of NR4A2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of EBF3 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of ISG20 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of CUEDC2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of EIF2B3 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of SIGLEC6 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of TNRC18 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of ETS1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of SPRED1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of YTHDC1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of CEBPB in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of SETD1B in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of PIGC in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of KDM2A in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of AMZ1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of PACSIN3 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of FOXN4 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of QKI in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of NPIPB15 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of TEC in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of KLHL26 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of M6PR in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of PMPCB in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of PRDM16 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of FOXL1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of SLC20A2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of TWSG1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of GCSAM in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of TMEM131L in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of ARHGEF1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of PTPRH in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of RNF11 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of KLLN in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of FAM83A in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of GAP43 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of POGZ in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of SIT1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of IKZF1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of MARCKSL1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of BTBD2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of FGD6 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of GNG12 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of SSC5D in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of AHNAK in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of C19orf38 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of APBB1IP in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of TSPAN1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of PTP4A3 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of NUDT4 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of EHHADH in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of UBASH3A in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of WT1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of ZEB2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of SPPL2C in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of GPR119 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of RTN3 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of RSPH3 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of FOXO6 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of C9orf152 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of CD44 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of HCK in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of SHISA3 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of GMIP in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of DNAJC27 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of GATA4 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of FADS3 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of ARHGAP15 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of SOCS3 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of RAP1GAP in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of FOXE1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of LAPTM5 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of CBLN3 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of TPCN2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of JMJD1C in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of DDI2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of CRTC3 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of EBF2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of PTPN7 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of HPCAL4 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of ANKRD12 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of MYO6 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of ULK1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of EBF1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of RAI2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of UBASH3B in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of SYNPO2L in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of KHDRBS2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of TMPRSS2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of SIGLEC10 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of LAPTM4B in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of NUDT10 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of NR4A3 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of PIP5K1A in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of KLF2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of P2RX5 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of SLCO5A1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of PARP12 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of NOXO1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of LEP in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of GCSAML in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of RASA2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of CD52 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of WDR72 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of TMEM185A in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of SYPL1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of DGKK in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of NHP2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of B3GNT5 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of HTR7 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of FOXF1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of SMAGP in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of FOXA3 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of NR4A1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of CD200 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of MAP4K5 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of SPN in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of STAT5A in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of SOX7 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of PIK3C2B in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of LPAR5 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of EPB41 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of NAA15 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of LAX1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of SMOC2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of ADCY1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of B4GALNT3 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of PTPN6 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of ZFP36 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of FCRL5 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of PTPRC in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of SOX18 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of GRB2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of MUC21 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of GATA3 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of CEACAM1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of TCF7L1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of WNK4 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of LRRC25 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of FOXO4 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of LIME1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of PTPN12 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of TOX in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of ITPKA in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of IKZF3 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of INPPL1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of MUC1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of CD244 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of ARHGDIB in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of PITX1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of SLA2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of LCK in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of GRAP in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of LAT2 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of LYN in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of MAP4K1 in primary CD4+ human T cells causally result in increased TNF-alpha secretion?,0
+Does activation of GFI1 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of SMAGP in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of MUC21 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of ST6GALNAC1 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of ITGB2 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of OSR2 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of MUC1 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of CD1C in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of GAL3ST4 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of FUT6 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of ST3GAL1 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of MS4A1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of LRRC15 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of TLE3 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of PRDM1 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of SPN in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of MUC12 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of PTPRC in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of HDAC9 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of NFIA in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of ELOVL6 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of GFI1B in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of IRX5 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of POU2F2 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of MS4A14 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of MS4A7 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of C5AR1 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of CD44 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of IQGAP2 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of CBFA2T3 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of JMJD1C in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of CD38 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of ALCAM in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of PLPP3 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of FCGR2B in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of PODXL in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of ARHGAP45 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of HIC1 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of BCL9L in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of MAML2 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of SPIB in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of CLIC4 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of SLA in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of PIK3AP1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of FAR1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of MAML1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of POU2AF1 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of ZEB2 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of SASH3 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of SLC9A3R1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of DOCK11 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of HES7 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of BCOR in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of PTPN6 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of TSPAN15 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of GAL3ST2 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of RAC2 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of FOXO4 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of AXL in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of SLC39A13 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of LIMK2 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of CADM1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of CAPN6 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of MAML3 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of CLDN18 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of ST3GAL2 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of VSIG8 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of ELOVL1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of IKZF3 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of CEBPE in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of SYK in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of FMNL3 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of MAP3K3 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of ICAM1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of EZR in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of FCGR1B in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of LCK in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of FMNL1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of ADGRG5 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of GRHL1 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of PNMA5 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of ZC3HAV1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of VCAM1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of BTK in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of ZNF746 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of FAM81A in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of SLA2 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of ZBTB7A in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of CD79B in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of ZNF683 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of CIITA in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of PPP3CA in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of ZBTB7B in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of BCL6 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of MSN in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of IER5L in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of ELOC in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of MAK in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of MAP3K10 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of MOB3A in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of ZNF311 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of FCRL3 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of LCA5L in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of ZDBF2 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of CIT in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of GCNT1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of TMEM119 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of KMT5B in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of SIX4 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of GYPA in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of ISL2 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of TP73 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of ZFX in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of SYT1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of MEX3B in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of RNF122 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of LPIN2 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of MED13 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of DBR1 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of MUC22 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of SIAH2 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of PWWP2B in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of POGLUT1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of CELF1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of DBN1 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of MYB in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of TTC39C in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of FAM49B in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of NRG4 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of PLA2G6 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of MSS51 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of CRIP2 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of FRMD3 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of VSIG1 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of DGKB in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of SORD in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of CD47 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of S100A11 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of C15orf59 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of CSNK1G3 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of STK10 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of PRAP1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of GDPGP1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of TRIM13 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of MS4A8 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of ADAD2 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of LAG3 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of LYL1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of NOMO2 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of NOMO3 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of PNMA8A in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of NOMO1 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of KCNS2 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of DOCK10 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of KLHL36 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of ZMYND8 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of SPTBN1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of KCNJ6 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of SLC30A7 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of VPS39 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of ZNF680 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of YY1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of CHAF1A in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of QSER1 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of UNC13D in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of CRYGD in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of IGLL1 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of PRSS36 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of RORC in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of TIMM23B in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of NANOS3 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of PIGR in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of MYH10 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of LAPTM5 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of LHX9 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of CIB1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of PLPPR1 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of TIMM23 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of DEFB1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of TMEM101 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of CD4 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of KRT23 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of FAM129B in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of MAG in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of C20orf196 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of ARRDC3 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of RAB44 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of KRT6A in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of JARID2 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of UBE2Q2 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of WNT9A in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of GRIK4 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of PPP2R5D in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of CA9 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of GK5 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of KEL in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of MPZL1 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of ZMIZ1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of PICALM in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of JADE2 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of TMPRSS5 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of CEACAM20 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of CD19 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of RDX in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of ZNF521 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of OBP2A in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of ARHGAP30 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of CPSF1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of PNPLA8 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of PCBP4 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of RPL5 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of CNTFR in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of SMARCA2 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of KDELR3 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of BLNK in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of PRKAR1A in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of CCDC136 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of FCER2 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of ANAPC2 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of GSTM2 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of SLC26A9 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of RBM38 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of REXO1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of FXYD5 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of AMPD2 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of UBALD2 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of FKBP11 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of SCN1B in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of MYC in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of AK2 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of VAV1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of GRK3 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of ZEB1 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of PPT1 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of ASIC2 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of RUNX1T1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of TTC6 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of DPH5 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of LACTBL1 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of POLR2H in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of RAP1GAP2 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of PTPN9 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of FCGR2A in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of CLIC2 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of SREBF1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of MOSPD1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of NIPBL in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of BCL9 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of ZCCHC14 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of IER5 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of SORBS3 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of RSG1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of NXPE4 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of RABEP2 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of BTBD19 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of ASAH1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of SHQ1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of TMEM9B in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of ACCS in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of NOP56 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of CLIC1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of TRIM33 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of EVL in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of HDGF in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of TMIE in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of ATP5C1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of CCNT1 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of CCDC88C in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of MIR1-1HG in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of MAP1B in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of THSD7A in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of SEMA4A in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of CACNA2D3 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of MED12L in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of ACSS1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of B3GNT6 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of TMOD1 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of PDE8A in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of CEACAM1 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of POFUT1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of ESRP1 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of FBRS in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of CPLX2 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of IQGAP1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of CTRC in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of PIK3CB in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of NUDT4 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of USP9X in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of PDK3 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of ZNF713 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of SHOX in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of TNFRSF21 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of NFKB2 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of PREX1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of VSIR in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of MYBPC2 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of TMEM187 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of SLC38A2 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of PROCR in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of NCOA3 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of FGD3 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of EMID1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of WIPF3 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of CNN3 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of LTBP3 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of ACTR1B in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of MIER3 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of SSFA2 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of NACC2 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of SEL1L3 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of GPX4 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of GMIP in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of ARPC3 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of CDK6 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of NAPEPLD in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of BHLHA15 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of SLC29A2 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of RAB1B in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of SH3KBP1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of ZBTB16 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of CDC42BPB in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of DUSP22 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of LYN in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of GP9 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of LRAT in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of B3GNT7 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of FEZ2 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of ZCCHC11 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of SERTAD2 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of COL8A1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of SPPL3 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of MRPS2 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of MYCBP2 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of FLI1 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of TBX22 in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of VPS37C in J774 macrophages causally result in phagocytic inhibition?,1
+Does activation of PSMD3 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of PMAIP1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of MAP2K3 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of PTOV1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of CMTM7 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of USP7 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of ABRAXAS1 in J774 macrophages causally result in phagocytic inhibition?,0
+Does activation of VAV1 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of IL2RB in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of CD28 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of IL2 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of CNR2 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of LCP2 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of GPR84 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of OTUD7B in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of DEPDC7 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of APOL2 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of P2RY14 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of HCAR2 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of IRX4 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of RUNX3 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of APOBEC3D in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of PLAGL1 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of TRIM21 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of FOSL1 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of PIK3AP1 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of FOXQ1 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of RRAS2 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of KRT81 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of EMP1 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of NLRC3 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of SP140L in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of RIPK3 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of APOBEC3A in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of KRT18 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of OTUD7A in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of AKT1 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of PRKCB in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of GRINA in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of DEF6 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of ZAP70 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of SOX21 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of CDKN2A in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of SLC16A1 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of FOSB in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of MAP2K6 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of PLCG2 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of IRX5 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of TAF15 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of MAP3K12 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of FPR2 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of VAV3 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of GPR171 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of DCTN5 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of ANXA2 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of EMP3 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of ADAM23 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of AFF3 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of ALX4 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of MAPK13 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of ARID1A in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of ITK in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of SERTM1 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of RAC2 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of CEP78 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of EPOP in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of TIGAR in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of SETX in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of ZNHIT3 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of PIK3R6 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of GPR17 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of VPS37D in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of ADAM19 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of DBP in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of TNFRSF1A in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of TRIM24 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of WIPF1 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of TNFRSF9 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of SPP2 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of CCR1 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of PROM1 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of SPIRE2 in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of BTK in primary CD4+ human T cells causally result in increased IL2 secretion?,1
+Does activation of LYPD8 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of PCYOX1L in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of CDH5 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of PDZK1IP1 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of COX6B1 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of OPRD1 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of SOX12 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of PSMB1 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of P2RY11 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of PRSS35 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of TP53TG3C in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of ECEL1 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of ANKRD17 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of MSRB1 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of HERC1 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of PROX2 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of TRA2B in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of SDR9C7 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of ZEB1 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of SORBS1 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of C19orf35 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of MAN1A1 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of ZNF740 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of PLXNB1 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of LAPTM4B in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of IRF4 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of GIGYF2 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of C4orf19 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of FERMT1 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of BATF in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of IPCEF1 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of FUT4 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of RTN3 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of ACE in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of AHR in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of LMO4 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of USP8 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of AMZ1 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of SLC39A2 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of CD200 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of SIT1 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of SENP6 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of NDUFAF6 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of STAT6 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of CPE in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of CD247 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of ISG15 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of CDYL in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of CDK6 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of LRRC52 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of SLCO5A1 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of OCSTAMP in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of BZW2 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of GABPB1 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of PSTPIP1 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of BTBD8 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of TAB2 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of PTPN12 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of LIME1 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of BACH2 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of S100A2 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of UBE2W in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of ANO10 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of HKDC1 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of RBMS3 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of RRM2 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of SMIM12 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of STK32C in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of CDK4 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of TCF12 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of TMEM235 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of ZNF148 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of FCGBP in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of METTL23 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of CXCL11 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of NEUROG2 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of PPL in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of PPARG in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of SAMD9 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of EPN3 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of EIF2B3 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of MAMLD1 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of LYZ in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of ARHGAP12 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of XDH in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of ARHGAP25 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of CAMK4 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of TOMM70 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of FAM102A in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of TBRG1 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of FOXI3 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of SUSD6 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of RAP1GAP in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of PACSIN3 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of GPHN in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of CALN1 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of PIK3C2B in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of FOXA3 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of RAB13 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of FARSA in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of CBLN3 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of HS3ST1 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of GPR35 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of STK10 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of HES3 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of STAT5A in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of CST5 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of NCEH1 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of MAP4K5 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of CYTH4 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of PLSCR1 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of MKLN1 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of SOX13 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of SIGLEC10 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of WNK4 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of LPAR5 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of MYC in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of FCRL5 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of GMIP in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of NR4A3 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of PTPN6 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of SPN in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of SPRED1 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of EIF3K in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of FBXO17 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of WDR81 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of GCSAM in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of B4GALNT3 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of PIP5K1A in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of CEBPB in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of P2RX5 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of EPB41 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of QRSL1 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of EOMES in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of PTPRC in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of FERMT2 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of SLC39A8 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of MYO6 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of UBASH3A in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of B3GNT5 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of CD244 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of PTPN22 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of MUC1 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of PUM1 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of SYPL1 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of GRB2 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of LRRC25 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of IKZF3 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of GFI1 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of TOX in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of ITPKC in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of CD52 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of ZEB2 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of IKZF1 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of NR4A1 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of SLA2 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of FOXL2NB in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of SMAGP in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of LAT2 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of INPPL1 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of CTAG1A in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of LYN in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of ITPKA in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of GRAP in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of ARHGDIB in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of MAP4K1 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does activation of CEACAM1 in primary CD4+ human T cells causally result in increased IL2 secretion?,0
+Does knockout of TRADD in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of MAP3K7 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of TNFRSF1A in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of IKBKG in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of IKBKB in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of RIPK1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of NFKBIA in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of FBXW11 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of SEPHS1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of CHUK in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of TRAF2 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of RBCK1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of CRTC3 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of DUSP1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of STAG2 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of TADA1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of SUPT7L in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of QRICH1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of RNF31 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of INO80C in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of SUPT3H in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of PDCL in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of NDC1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of PAXIP1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of MBD3 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of RANBP1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of VHL in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of ACTR5 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of ELAVL1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of PPP2R2A in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of MAP2K5 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of CRTC2 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of PAGR1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of THAP12 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of UBE3D in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of TRAF7 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of FAM58A in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of MRGBP in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of RPRD1B in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of RIC8A in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of NUP50 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of NUP188 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of WRB in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of BPTF in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of FAM204A in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of SMARCA5 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of TAF6L in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of STRIP1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of PDS5A in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of SGF29 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of FGFR1OP2 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of KATNA1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of PPIH in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of NUP35 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of TAF5L in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of CEBPB in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of ATXN2L in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of OTUD6B in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of SLMAP in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of LZTR1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of CMTR1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of UHRF1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of ACACA in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of MBTPS1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of INO80E in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of PDCD5 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of CLK3 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of LIPT1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of PPP2R3C in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of TNPO1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of INO80B in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of ITGAV in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of KMT2A in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of SP1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of SBNO1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of PRKDC in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of METAP1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of YARS2 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of UBE2D3 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of CREBBP in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of MEN1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of VPS41 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of ITGB5 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of GOLGA6L6 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of SLTM in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of DOT1L in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of MAP3K2 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of RBM12 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of SSR1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of ZFX in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of PRKRIP1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of ACTR3 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of CABIN1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of SPG21 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of KCTD10 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of PAK6 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of DEXI in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of TGM7 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of NUDCD1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of DDIT4 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of PITPNB in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of VPS29 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of CHGB in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of MESD in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of BRINP2 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of TFAP4 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of MTA2 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of COMMD4 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of CYP1A1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of NHLRC2 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of SPNS1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of G3BP2 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of CDYL in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of CELF6 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of DCUN1D1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of KATNBL1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of MOB4 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of ARPIN in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of NUP43 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of DUOX2 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of MAX in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of NIPBL in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of DCAF15 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of SIRT6 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of PPP2CA in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of EED in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of CNTNAP1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of ATXN7L3 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of CYFIP1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of PARN in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,1
+Does knockout of IMPDH2 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,0
+Does knockout of UBR4 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,0
+Does knockout of HUWE1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,0
+Does knockout of TMEM164 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,0
+Does knockout of COX10 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,0
+Does knockout of UMPS in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,0
+Does knockout of PPAT in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,0
+Does knockout of GDI2 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,0
+Does knockout of UBP1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,0
+Does knockout of MOCS3 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,0
+Does knockout of PDPK1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,0
+Does knockout of AIP in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,0
+Does knockout of EIF3M in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,0
+Does knockout of RABGEF1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,0
+Does knockout of GPS2 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,0
+Does knockout of PPP5C in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,0
+Does knockout of STRAP in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,0
+Does knockout of ARHGAP1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,0
+Does knockout of ZCCHC11 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,0
+Does knockout of NR2C2AP in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,0
+Does knockout of CTU1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,0
+Does knockout of ZBTB21 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,0
+Does knockout of YY1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,0
+Does knockout of PAICS in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,0
+Does knockout of TMEM209 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,0
+Does knockout of AHR in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,0
+Does knockout of HECTD1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,0
+Does knockout of KLHDC10 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,0
+Does knockout of MAPK14 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,0
+Does knockout of AMBRA1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,0
+Does knockout of VCPIP1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,0
+Does knockout of PREP in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,0
+Does knockout of CSDE1 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,0
+Does knockout of ATIC in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,0
+Does knockout of TNFAIP3 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,0
+Does knockout of HDAC3 in HeLa cervical adenocarcinoma cells causally result in increased RelA nuclear translocation?,0